Soterenol

Soterenol

SCHEMBL932231

CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1ccc(O)c(NS(C)(=O)=O)c1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB2

The experimentally established mechanism targets of Soterenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 2/20 0.62
ADRB3 P13945 14/20 0.76
MEN1 O00255 2/20 0.57
LMNA P02545 2/20 0.57
BLM P54132 2/20 0.57
KMT2A Q03164 2/20 0.57
KDM4E B2RXH2 1/20 0.57
CASP1 P29466 1/20 0.57
CASP7 P55210 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HIF1A Q16665 1/20 0.57
APEX1 P27695 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11029065 0.88 ADRB3 (0.81) ADRB3ADRB2
Hydrochloric Acid SCHEMBL11027634 0.87 ADRB3 (0.80) ADRB3ADRB2
Soterenol SCHEMBL119138 0.87 ADRB3 (1.00) ADRB3ADRB2MEN1LMNABLM
Soterenol SCHEMBL635183 0.86 ADRB3 (0.97) ADRB3ADRB2MEN1LMNABLM
Soterenol SCHEMBL1652640 0.85 ADRB3 (0.95) ADRB3ADRB2MEN1LMNAKMT2A
Terbutaline SCHEMBL8761821 0.84 BLM (0.67) ADRB3ADRB2MEN1LMNABLM
Terbutaline SCHEMBL1417928 0.84 ADRB2 (0.70) ADRB3ADRB2MEN1LMNABLM
Terbutaline SCHEMBL6906249 0.81 ADRB2 (0.81) ADRB3ADRB2MEN1LMNABLM
Zinterol SCHEMBL1551570 0.81 ADRB2 (0.85) ADRB3ADRB2
Albuterol SCHEMBL9238360 0.80 ADRB2 (0.75) ADRB3ADRB2MEN1LMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011005352-A1 SUSTAINED-RELEASE DRUG DELIVERY COMPOSITIONS AND METHODS UPM PHARMACEUTICALS, INC. (US) 2011-01-13 WO disclosed
US-20100092562-A1 SUSTAINED-RELEASE DRUG DELIVERY COMPOSITIONS AND METHODS UPM PHARMACEUTICALS, INC. 2010-04-15 US disclosed